Correlates of leukocyte counts in men

Annals of Epidemiology

Volumn 6, Issue 1, 1996, Pages 74-82

  Freedman, David S ^a,e   Joesoef, M Riduan ^b   Barboriak, Joseph J ^c   Stallone, Daryth D ^d   Byers, Tim ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Center for Science in the Public Interest   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

blacks; cigarette smoking; ischemic heart disease; Leukocytes

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; ETHNIC GROUP; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030021946     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/1047-2797(95)00091-7     Document Type: Article

References (46)

1. Grimm RH, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality, JAMA. 1985;254:1932-1937.
2. De Labry LO, Campion, EW, Glynn RJ, Vokonas PS. White blood cell count as a predictor of mortality: Results over 18 years from the Normative Aging Study, J Clin Epidemiol. 1990;43:153-157.
3. Friedman GD, Klatsky AL, Sigelaub AB. The leukocyte count as a predictor of myocardial infarction, N Engl J Med. 1974;290:1275-1278.
4. Zalokar JB, Richard JL, Claude JR. Leucocyte count, smoking and myocardial infarction, N Engl J Med. 1981;304:465-468.
5. Prentice RL, Szatrowski TP, Fujikura T, Kata H, Mason MW, Hamilton HH. Leukocyte counts and coronary heart disease in a Japanese cohort, Am J Epidemiol. 1982;116:496-509.
6. Yarnell JWG, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease: The Caerphilly and Speedwell Collaborative Heart Disease studies, Circulation. 1991;83;836-844.
7. Mänttäri M, Manninen V, Koskinen P, et al. Leukocytes as a coronary risk factor in a dyslipidemic male population, Am Heart J. 1992;123: 873-877.
8. Phillips AN, Neaton JD, Cook DG, Grimm RH, Shaper AG. Leukocyte count and risk of major coronary heart disease events, Am J Epidemiol. 1992;136:59-70.
9. Kannel WB, Anderson K, Wilson PWF. White blood cell count and cardiovascular disease. Insights from the Framingham Study, JAMA. 1992;267:1253-1257.
10. Gillum RF, Ingram DD, Makuc DM. White blood cell count, coronary heart disease, and death: The NHANES I Epidemiologic Follow-up Study, Am Heart J. 1993;125:855-863.
11. Olivares R, Ducimetière P, Claude JR. Monocyte count: A risk factor for coronary heart disease?, Am J Epidemiol. 1993;137:49-53.
12. Friedman GD, Selby JV, Quesenberry CP Jr. The leukocyte count: A predictor of hypertension, J Clin Epidemiol. 1990;43:907-911.
13. Ensrud K, Grimm RH. The white blood cell count and risk for coronary heart disease, Am Heart J. 1992;124:207-213.
14. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic diseases, JAMA. 1987;257:2318-2324.
15. Schmitz G, Lackner KJ. The value of cellular markers for the assessment of cardiovascular risk, Curr Opin Lipidol. 1993;4:461-470.
16. Stuart J, George AJ, Davies AJ, Aukland A, Hurlow RA. Hematological stress syndrome in atherosclerosis, J Clin Pathol. 1981;34:464-467.
17. Friedman GD, Siegelaub AB, Seltzer CC, Feldman R, Collen MF. Smoking habits and the leukocyte count, Arch Environ Health. 1973; 26:137-143.
18. Knoke JD, Hunninghake DB, Heiss G. Physiological markers of smoking and their relation to coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial, Arteriosclerosis. 1987;7: 477-482.
19. Petitti DB, Kipp H. The leukocyte count: Associations with intensity of smoking and persistence of effect after quitting, Am J Epidemiol. 1986;123:89-95.
20. Carel RS, Eviatar J. Factors affecting leukocyte count in healthy adults, Prev Med. 1985;14:607-619.
21. Nieto FJ, Szklo M, Folsom AR, Rock R, Mercuri M. Leukocyte count correlates in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study, Am J Epidemiol. 1992;136:525-537.
22. Ingram DD, Gillum RF. Leukocyte count and cardiovascular risk factors, J Natl Med Assoc. 1992;84:1041-1043.
23. Friedman GD, Tekawa I, Grimm RH, et al. The leucocyte count: Correlations and relationship to coronary risk factors. The CARDIA Study, Int J Epidemiol. 1990;19:889-893.
24. Folsom AR, Conlan MG, Davis CE, Wu KK. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults, Ann Epidemiol. 1992;2:481-494.
25. Hansen LK, Grimm RH Jr, Neaton JD. The relationship of white blood cell count to other cardiovascular risk factors, Int J Epidemiol. 1990;19:881-888.
26. Centers for Disease Control Vietnam Experience Study. Health status of Vietnam veterans. Volume I: Psychosocial characteristics, JAMA. 1988;259:2701-2707.
27. Centers for Disease Control. Health Status of Vietnam Veterans. Volume III: Medical Examination. Atlanta, GA: US Department of Health and Human Services; 1989.
28. Centers for Disease Control. Health Status of Vietnam Veterans. Supplement A: Laboratory Methods and Quality Control. Atlanta, GA: US Department of Health and Human Services; 1989.
29. US Department of Health and Human Services (DHHS). National Drug Code Directory. 1985 ed. DHHS publication no. (FDA) 85-1077. Washington, DC: DHHS; 1985.
30. Dinerman JL, Mehta JL. Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevance, J Am Coll Cardiol. 1990;6:207-222.
31. de Servi S, Ricevuti G, Mazzone A, et al. Granulocyte function in coronary artery disease, Am J Cardiol. 1991;68:64B-68B.
32. Jacob HS, Hammerschmidt DE. Complement-induced granulocyte aggregation, JAMA. 1981;245:2013-2017.
33. Ludwig PW, Hunninghake DB, Hoidal JR. Increased leukocyte oxidative metabolism in hyperlipoproteinemia, Lancet. 1982;2:348-350.
34. Tell GS, Grimm RH, Vellar OPD, Theodorsen L. The relationship of white cell count, platelet count, and hematocrit to cigarette smoking in adolescents: The Oslo Youth Study, Circulation. 1985;72:971-974.
35. Shoenfeld Y, Weinberger A, Avisher A, et al. Familial leukopenia among Yemenite Jews, Isr J Med Sci. 1978;14:1271-1274.
36. Chan-Yeung M, Ferreira P, Frohlich J, Schulzer M, Tan F. The effects of age, smoking, and alcohol on routine laboratory tests, Am J Clin Pathol 1981;75:320-326.
37. Kanwar KC, Tikoo A. Hematological lesions in rat following heavy alcohol ingestion, J Environ Pathol Toxicol Oncol. 1992;11:241-245.
38. Gillum RF. Peripheral leukocyte count and pulmonary function in a national sample of women and men, Ann Epidemiol. 1991;1:525-531.
39. Facchini F, Hollenbeck CB, Chen YN, Chen YDI, Reaven GM. Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women, J Intern Med. 1992;232:267-272.
40. Feldman DL, Mogelesky TC, Liptak BF, Gerrity RG. Leukocytosis in rabbits with diet-induced atherosclerosis, Arterioscler Thromb. 1991;11:985-994.
41. Yarnell JWG, Sweetnam PM, Elwood PC, et al. Hemostatic factors and ischaemic heart disease. The Caerphilly study, Br Heart J. 1985; 53:483-487.
42. Jennings BH, Andersson KE, Johansson SÅ. Assessment of the systemic effects of inhaled glucocorticosteroids: The influence of blood sampling technique and frequency on plasma cortisol and leucocytes, Eur J Clin Pharmacol. 1990;39:127-131.
43. Landman R, Düring M, Gudat F, Wesp M, Harder F. Beta-adrenergic regulation of the blood lymphocyte phenotype distribution in normal subjects and splenectomized patients, Adv Exp Med Biol. 1985;186: 1051-1062.
44. Nawabi IU, Ritz ND. Agranulocytosis due to propranolol, JAMA. 1973;223:1376-1377.
45. Winkel P, Statland BE, Saunders AM, Osborn H, Kupperman H. Within-day physiologic variation of leukocyte types in healthy subjects as assayed by two automated leukocyte differential analyzers, Am J Clin Pathol. 1981;75:693-700.
46. Dutcher TF. Leukocyte differentials: Are they worth the effort?, Clin Lab Med 1984;4:71-87.